Cost-Effectiveness of Drug Therapies in Management of Hypertension in a Nigerian Teaching Hospital: a Utility-Based Analysis

Simple item page
dc.contributor.authorJamiu Muslim Olakunle
dc.contributor.authorGiwa Halima Bukola
dc.contributor.authorElegbede Busayo Jumoke
dc.contributor.authorAiyelero Medinat Oyeronke
dc.contributor.authorShittu Abiodun Oyetunji
dc.contributor.authorNjinga Stan
dc.contributor.authorAbdul Abdulraheem
dc.contributor.authorGiwa Abdul-fatihi Salaudeen
dc.contributor.authorGiwa Abdulganiyu
dc.contributor.authorElegbede Elijah Olusegun
dc.date.accessioned2026-02-04T15:38:59Z
dc.date.available2026-02-04T15:38:59Z
dc.date.issued2025-11-25
dc.description.abstractABSTRACT: Efficient resource allocation is vital for managing hypertension in Nigeria due to the high disease burden and limited healthcare resources. This study aims to assess the cost effectiveness of hypertension therapies at the University of Ilorin Teaching Hospital over one year by reviewing drug use, analyzing costs effectiveness of treatment options and examining their impact on healthcare policy and resource allocation. A sample size of 356 case notes was derived from 40,009 ambulatory hypertensive patients. The drug utilization study involved a one-year retrospective review of the 356 case notes, conducted from January to December 2023. The EuroQol 5-Dimensions 5-Level questionnaire (EQ-5D-5L) was used to determine the effectiveness of treatment options based on qualityadjusted life years (QALYs). Of the 693 prescriptions identified, 94 (13.56%) contained monotherapy, 328(47.3%) two-drug combination and 271(39.11%) three-drug combination. Amlodipine + lisinopril appeared to be more costeffective than amlodipine + telmisartan, which in turn was more cost-effective than both amlodipine + indapamide and amlodipine + ramipril, leaving amlodipine+ lisinopril as the most cost effective out of analysed options for the Nigeria healthcare system. ICERs obtained were robust to parameter variation on probabilistic sensitivity analysis. Inclusion of amlodipine + lisinopril in the WHO essential medicine list, hospital formularies, and standard treatment guidelines as components of drug policy is justified and would promote rational drug use, improve treatment outcomes and optimize resource utilization in the management of hypertension in Nigeria.
dc.description.sponsorshipSelf
dc.identifier.citationDhaka Univ. J. Pharm. Sci. 24(2): 147-156, 2025 (December) DOI: https://doi.org/10.3329/dujps.v24i2.86365
dc.identifier.urihttps://uilspace.unilorin.edu.ng/handle/123456789/16929
dc.language.isoen
dc.publisherDhaka Univ. J. Pharm. Sci
dc.subjectHypertension
dc.subjectantihypertensives
dc.subjectcost -minimization analysis
dc.subjectNigerian teaching hospital.
dc.titleCost-Effectiveness of Drug Therapies in Management of Hypertension in a Nigerian Teaching Hospital: a Utility-Based Analysis
dc.typeArticle

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
DHAKA UNI JOURNAL 2025.pdf
Size:
294.02 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections